Loading...
XIDX
BMHS
Market cap80mUSD
Nov 12, Last price  
155.00IDR
Name

Bundamedik Tbk PT

Chart & Performance

D1W1MN
XIDX:BMHS chart
P/E
111.65
P/S
0.86
EPS
1.39
Div Yield, %
0.36%
Shrs. gr., 5y
0.14%
Rev. gr., 5y
10.01%
Revenues
1.55t
+4.47%
852,232,962,250964,892,513,4291,148,144,381,7121,710,759,215,7961,658,687,911,2221,488,197,483,3711,554,685,010,000
Net income
11.94b
+60.08%
5,127,896,26931,316,953,346118,460,085,776315,363,896,754128,931,855,6627,461,134,36811,943,515,000
CFO
33.98b
-33.94%
43,790,614,96189,715,033,956190,358,533,077349,438,392,180237,469,070,97451,438,728,48433,979,487,000
Dividend
Jun 10, 20240.56 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.
IPO date
Jul 06, 2021
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT